Schonfeld Strategic Advisors LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in VTGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,155

+$810 QoQ

Shares Held

26,589

+22.3% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,155	26,589	+22.3%	Shares	Sole	2026-05-15
2025-12-31	$14,345	21,736	+99.7%	Shares	Sole	2026-02-17
2025-09-30	$38,634	10,883	-92.1%	Shares	Sole	2025-11-14
2023-09-30	$725,740	138,500	-20.9%	Shares	Sole	2023-11-14
2022-06-30	$154,087	175,100	+0.1%	Shares	Sole	2022-08-15
2022-03-31	$216,875	174,900	-54.7%	Shares	Sole	2022-05-16
2021-12-31	$753,089	386,200	-8.6%	Shares	Sole	2022-02-14
2021-09-30	$1,157,649	422,500	-31.1%	Shares	Sole	2021-11-16
2021-06-30	$1,932,839	613,600	+127.4%	Shares	Sole	2021-11-16
2021-03-31	$574,671	269,799	+245.5%	Shares	Sole	2021-05-17
2020-12-31	$151,513	78,100	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.